In addition, all four genetic variants tested were associated with pancreatic cancer (OR for non-O ABO genotypes ranged from 1.25 to 1.58, and the per-allele odds ratios for the other three risk SNPs ranged from 1.18 to 1.49). The gene discussed is ABO; the disease is pancreatic neoplasm.